- Tosti A, Piraccini BM. Nail disorders. In Bolognia JL, Jorizzo JL, Rapini RP, eds. Dermatology, vol 1. London: Mosby, 2003: 1068.
- van de Kerkhof PCM. Psoriasis. In Bolognia JL, Jorizzo JL, Rapini RP, eds. Dermatology, vol 1. London: Mosby, 2003: 132–137.
- Christopher E. Pustular eruptions of the palms and soles. In Fitzpatrick TB, Eisen AZ, Woloff K, Freedberg IM, Austen KF, eds. Dermatology in General Medicine, vol 1. New York: McGraw-Hill, 1993: 651–653.
- Sotririadis D, Patsatsi A, Sotiriou E, Papagaryfallou I, Chrysomallis F. Acrodermatitis continua of Hallopeau on toes successfully treated with a two-compound product containing calcipotriol and betamethasone dipropionate. J Dermatol Treat 2007;18 (5): 315–318.
- Mang R, Ruzicka T, Stege H. Successful treatment of acrodermatitis continua of Hallopeau by the tumour necrosis factor-alpha inhibitor infliximab (Remicade). Br J Dermatol 2004;150 (2): 379–380.
- Ahmad K, Rogers S. Tw o years of experience with etanercept in recalcitrant psoriasis. Br J Dermatol 2007;156 (5): 1010–1014.
- Ahmad K, Rogers S. Three years' experience with infliximab in recalcitrant psoriasis. Clin Exp Dermatol 2006;31 (5): 630–633.
- Seishima M, Mizutani Y, Shibuya Y, Nagasawa C, Aoki T. Efficacy of granulocyte and monocyte adsorption apheresis for pustular psoriasis. Ther Apher Dial 2008;12 (1): 13–18.
- Menter A, Feldman SR, Weinstein GD, Papp K, Evans R, Guzzo C, Li S, Dooley LT, Arnold C, Gottlieb AB. A randomized comparison of continuous vs. intermittent infliximab maintenance regimens over 1 year in the treatment of moderate-to-severe plaque psoriasis. J Am Acad Dermatol 2007;56 (1): 31.e1–15.
Baylor University Medical Center Proceedings
The peer-reviewed journal of Baylor Scott & White Health
Volume 22, 2009 - Issue 2